metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Most often read
Journal Information

Most often read

52533
Anti-hepatitis B virus activity of food nutrients and potential mechanisms of action
Alexis Jose-Abrego, Ingrid Rivera-Iñiguez, Luis A. Torres-Reyes, Sonia Roman
Ann Hepatol. 2023;28:100766
52533
Full text access
14138
Intravenous albumin in cirrhosis: Updated clinical uses and novel perspectives
Roberta Gagliardi, Nicola Zeni, Salvatore Piano
Ann Hepatol. 2023;28:101150
14138
Full text access
13425
Liver diseases: Perspective from the Philippines
Eric David Ornos, Karl Jeffrey Murillo, Janus P. Ong
Ann Hepatol. 2023;28:101085
13425
Full text access
9025
A thorny matter: Spur cell anemia
Ruchi Sharma, Carol J. Holman, Kyle E. Brown
Ann Hepatol. 2023;28:100771
9025
Open access
7821
What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease?
Ingrid Rivera-Iñiguez, Arturo Panduro, Sonia Roman, Karina González-Aldaco
Ann Hepatol. 2023;28:100874
7821
Open access
5757
New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD
Louise Torres, Alice Schuch, Larisse Longo, Bruna Bressan Valentini, Gabriela Schneider Galvão, Eduardo Luchese, Carlos Pinzon, Rodrigo Bartels, Mário Reis Álvares-da-Silva
Ann Hepatol. 2023;28:100774
5757
Open access
5153
Consensus document on acute-on-chronic liver failure (ACLF) established by the Mexican Association of Hepatology
Aldo Torre, Laura Esthela Cisneros-Garza, Mauricio Castillo-Barradas, Nalu Navarro-Alvarez, Ricardo Sandoval-Salas, María Sarai González-Huezo, José Luís Pérez-Hernández, Osvely Méndez-Guerrero, ... Francisco Alfonso Solís-Galindo
Ann Hepatol. 2023;28:101140
5153
Full text access
5022
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists
Lucy Gracen, Withma Muthukumara, Melanie Aikebuse, Anthony Russell, James O'Beirne, Katharine M. Irvine, Suzanne Williams, Gaurav Puri, ... Elizabeth E. Powell
Ann Hepatol. 2023;28:101142
5022
Full text access
3574
Severe anemia is associated with increased short-term and long-term mortality in patients hospitalized with cirrhosis
Haotang Ren, Hai Li, Guohong Deng, Xianbo Wang, Xin Zheng, Yan Huang, Jinjun Chen, Zhongji Meng, ... Yu Shi
Ann Hepatol. 2023;28:101147
3574
Full text access
3396
Immunotolerance in liver transplantation: a primer for the clinician
Juanita Pérez-Escobar, Jose Victor Jimenez, Erika Faride Rodríguez-Aguilar, Maximiliano Servín-Rojas, Jesus Ruiz-Manriquez, Luisa Safar-Boueri, Eduardo Carrillo-Maravilla, Miquel Navasa, Ignacio García-Juárez
Ann Hepatol. 2023;28:100760
3396
Open access
3298
Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanisms
Xiaoyi Wang, Zhen Yang, Ying Ran, Long Li, Bangmao Wang, Lu Zhou
Ann Hepatol. 2023;28:101121
3298
Full text access
3152
Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: Systematic review and meta-analysis
Daniela Contreras, Alejandra González-Rocha, Patricia Clark, Simón Barquera, Edgar Denova-Gutiérrez
Ann Hepatol. 2023;28:100873
3152
Open access
3103
Body weight loss and glycemic control on the outcomes of patients with NAFLD. The role of new antidiabetic agents
Diego García-Compeán, Ramesh Kumar, Ángel Noe del Cueto-Aguilera, Héctor Jesús Maldonado-Garza, Jesús Zacarías Villarreal-Pérez
Ann Hepatol. 2023;28:100751
3103
Full text access
2507
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis
Mark Muthiah, Cheng Han Ng, Kai En Chan, Clarissa Elysia Fu, Wen Hui Lim, Darren Jun Hao Tan, Benjamin Nah, Gwyneth Kong, ... Mazen Noureddin
Ann Hepatol. 2023;28:100762
2507
Open access
2481
The treatment of diabetes in advanced liver disease: change of a paradigm
Maria Letizia Petroni, Lucia Brodosi, Giulio Marchesini
Ann Hepatol. 2023;28:100772
2481
Open access
2410
Metabolic dysfunction: The silenced connection with fatty liver disease
Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Manuel Romero-Gómez, Mohammed Eslam, Nahum Méndez-Sánchez
Ann Hepatol. 2023;28:101138
2410
Full text access
2363
Comparison of diagnostic performance of AFP, DCP and two diagnostic models in hepatocellular carcinoma: a retrospective study
Yongwu Chen, Xiuli Yang, Yanfei Shao, Hongying Zhao, Jinying Jiang, Ping Huang, Yi Lu, Zixue Xuan
Ann Hepatol. 2023;28:101099
2363
Full text access
2239
Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver disease
Jing Liu, Haifeng Lv, Jie Wang, Qianru Zhu, Gongying Chen, Yanming Jiang, Ke Zhao, Li Shao, ... Xiaoben Pan
Ann Hepatol. 2023;28:100892
2239
Full text access
1957
Combined effects of hyponatremia and hepatic encephalopathy on inpatient mortality
Mahak Chauhan, Talan Zhang, Paul J. Thuluvath
Ann Hepatol. 2023;28:101084
1957
Full text access
1925
Validation of the Hepamet fibrosis score in a multi-ethnic Asian population
Shi-En Chong, Felicia Chang, Kee-Huat Chuah, Pavai Sthaneshwar, Nik Raihan Nik Mustapha, Sanjiv Mahadeva, Wah-Kheong Chan
Ann Hepatol. 2023;28:100888
1925
Full text access
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos